Druckenmiller’s 4Q13 Portfolio Changes

Stan Druckenmiller is a billionaire, and was the long-time manager of Duquesne Capital. Now, he oversees a family office, but his investing strategy is mostly the same. Here are some things we noticed when comparing Druckenmiller’s filing for the end of December with previous filings:

DUQUESNE CAPITAL

New buys in big pharma. One of the more striking themes from Druckenmiller’s 4Q13 13F filing was an increased bet on drug manufacturers. He initiated new positions in two branded drug manufacturers, Bristol-Myers Squibb (BMY) and AstraZeneca (AZN) as well as a generic specialist with a growing branded business, Teva Pharmaceutical Industries (TEVA). At the same time, he increased his stake in Johnson & Johnson (JNJ) by 82%. With each company having different drugs in various stages of development, these stakes could be a diversified bet on one or more new blockbuster drugs getting one step closer to receiving FDA approval or a more defensive portfolio posture following the strong market rally in 2013.

Fedex. Druckenmiller initiated a new position in shipping company Fedex (FDX), which became his second largest holding. Although customers have been opting for cheaper delivery options vs. FDX’s express shipping service, the seasonally strong holiday season and benefits from recent restructuring efforts could have been reason enough to buy this stock during 4Q.

Wireless towers. Another new theme was Druckenmiller’s new positions in wireless communication tower operators Crown Castle International (CCI) and SBA Communications (SBAC). This seems to be a bet that, following American Tower’s (AMT) conversion to a REIT, competitors will follow suit. Subsequently, CCI announced in early January that it will operate as a REIT effective January 1, 2014.

Still bullish on tech. Continuing a theme from the previous quarter, Druckenmiller remains bullish on two tech heavyweights, Google (GOOG) and Amazon (AMZN). He increased his position in GOOG, which rallied 28% in 4Q13, by 4% and cemented its status as his top holding, accounting for whopping 17.4% of his portfolio. Similarly, AMZN, a newly initiated position during 3Q13 that also returned 28% in 4Q13, maintained its fourth place ranking in the portfolio. Although both companies are leaders in their respective fields, AMZN’s valuation multiples are clearly higher, given investor expectations that its continued dominance in online retailing will eventually lead to lower spending and higher profitability. On the other hand, GOOG is already highly profitable, which is reflected in its estimates and, hence, its more reasonable valuation levels.

Energy. Another theme that continued from 3Q13 was a bullish bet on oil and gas, with Druckenmiller increasing his exposure to oilfield services provider Halliburton (HAL) by 30% and independent exploration and production company Pioneer Natural Resources (PXD) by 38%, while maintaining Schlumberger (SLB) as his top two holding. In addition, he initiated new positions in two refiners, Valero Energy (VLO) and Marathon Petroleum (MPC), as well as another oilfield services company, Baker Hughes (BHI). On a related note, Druckenmiller seems to be making a bullish bet on another commodity, aluminum, via its new purchase of Alcoa (AA).

Sales. Druckenmiller sold out his entire stakes in Nokia (NOK) and Herbalife (HLF) during 4Q, which was a bit surprising as both names were new purchases during 3Q. However, given the 25% / 13% rally in NOK / HLF, respectively, during the quarter, it is safe to assume Druckenmiller made a tidy profit on these stocks.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!